Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:02:24.210Z.
Calculation as of: 2026-10-06T17:02:24.210Z.
Quote observation: 2026-10-06T17:00:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9cd3ead22764b77a02cf3e742533c366d0c9255af04c84535b20f2b2666bee2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Gain Therapeutics, Inc.
Market Cap
$71.87M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$70.30M
Free Cash Flow Yield
N/A
TTM Avg
6.20%
3Y Avg
5.62%
5Y Avg
4.88%
Market Cap
$69.48M
Free Cash Flow Yield
28.18%
TTM Avg
14.79%
3Y Avg
25.02%
5Y Avg
20.90%
Market Cap
$69.07M
Free Cash Flow Yield
N/A
TTM Avg
0.09%
3Y Avg
0.09%
5Y Avg
0.09%
Market Cap
$67.93M
Free Cash Flow Yield
185.24%
TTM Avg
137.42%
3Y Avg
137.42%
5Y Avg
137.42%
Market Cap
$76.14M
Free Cash Flow Yield
21.85%
TTM Avg
19.39%
3Y Avg
7.46%
5Y Avg
7.46%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $71.87M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $70.30M | N/A | 6.20% | 5.62% | 4.88% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 28.18% | 14.79% | 25.02% | 20.90% |
| MindWalk Holdings Corp. (HYFT)vs › | $69.07M | N/A | 0.09% | 0.09% | 0.09% |
| Fortress Biotech, Inc. (FBIO)vs › | $67.93M | 185.24% | 137.42% | 137.42% | 137.42% |
| iBio, Inc. (IBIO)vs › | $67.84M | N/A | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | 21.85% | 19.39% | 7.46% | 7.46% |
| Outset Medical, Inc. (OM)vs › | $76.19M | N/A | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $76.69M | N/A | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
